ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA ALL explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA ALL trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with tough-to-treat leukemia relapse
Disease control Recruiting nowThis study tests whether adding the drug bortezomib to standard chemotherapy helps children and teens with high-risk relapsed acute lymphoblastic leukemia (ALL) achieve remission and live longer. About 250 participants under 18 will be randomly assigned to receive either standard…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Phase: PHASE2 • Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated May 17, 2026 01:34 UTC
-
New CAR-T study tracks immune cells in blood cancer fight
Disease control Recruiting nowThis study is for people with certain blood cancers (DLBCL, PMBCL, or ALL) that have not responded to at least two prior treatments. It will track how well the patient's own modified immune cells (CAR-T cells) grow and last in the body after infusion. The goal is to understand ho…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
Cord blood transplants expanded to thousands in new access study
Disease control Recruiting nowThis study gives people with blood cancers, immune disorders, and other serious diseases access to unlicensed cord blood units for transplant. It includes both children and adults of any age. The main goal is to see how well the body recovers its white blood cells after the trans…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Early access to promising blood cancer drug for those with no other options
Disease control AVAILABLEThis program provides early access to venetoclax, a targeted therapy for several blood cancers including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and multiple myeloma. It is for people who have no other suitable treatments and cannot join a clinical trial…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Sponsor: AbbVie • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Last-Resort CAR-T therapy made available for desperate patients
Disease control AVAILABLEThis program provides access to a cancer treatment called tisagenlecleucel (Kymriah) for people with lymphoma, leukemia, or other conditions where standard treatments have failed. It is for patients who cannot join a clinical trial and have no other good options. The goal is to o…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
New cord blood transplant method could boost survival in tough blood cancers
Disease control Recruiting nowThis study is testing an improved method for cord blood transplants in adults with high-risk blood cancers like leukemia and lymphoma. The goal is to see if this optimized approach helps patients live longer and have fewer side effects. About 54 participants will receive the tran…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
Laughter yoga tested as pain relief for kids with cancer
Symptom relief Recruiting nowThis study tests whether a home-based program of laughter and fun yoga can lower pain in children aged 2-10 with acute lymphoblastic leukemia who are receiving chemotherapy. Sixty children will be randomly assigned to either the laughter and yoga program plus usual care, or usual…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Phase: NA • Sponsor: Bahaa Bou Dargham • Aim: Symptom relief
Last updated May 17, 2026 01:29 UTC
-
Earbud zaps insomnia in leukemia survivors
Symptom relief Recruiting nowThis study tests a small, non-invasive earbud that gently stimulates a nerve in the ear to see if it can improve sleep in adults who survived childhood leukemia and now have insomnia. About 40 participants will use either the active device or a sham (inactive) version nightly for…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC
-
Massive study aims to uncover why cancer treatments fail in poorer nations
Knowledge-focused Recruiting nowThis study will look back at the medical records of 18,000 children, adolescents, and young adults with cancer in low- and middle-income countries. The goal is to understand how often treatment fails or causes serious side effects, especially for acute lymphoblastic leukemia and …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Sponsor: Resonance, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 01:32 UTC
-
New study maps nerve pain in kids battling leukemia
Knowledge-focused Recruiting nowThis study follows 173 children aged 8-17 with acute lymphoblastic leukemia to understand how chemotherapy affects their nerves. Researchers will track symptoms like tingling or numbness over several weeks and look for factors like age, diet, or mood that might predict worse nerv…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA ALL
Sponsor: The Hong Kong Polytechnic University • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC